Artificial Intelligence

With 21% of voice actors reporting job losses to AI, a national association is taking its fight to D.C. to demand policy action and protect human creativity.

With compliance costs soaring, Spring Labs' $5M funding round will scale its AI agents to automate the execution of regulatory tasks for financial firms.

Forrester's new report highlights Airia as enterprises grapple with governing the new wave of autonomous, agentic AI systems that defy old rules.

A historic 142 deals and $1.67 trillion in assets changed hands in Q1 2026, as private equity, tech, and global ambitions fuel a record consolidation wave.

Diagnostic leader Bracco enters the cell therapy market with BubbleGen, a novel microbubble tech that promises to streamline complex manufacturing.

A new national agreement brings QuVa Pharma's AI-powered drug diversion software to thousands of hospitals, promising a high-tech solution to a hidden crisis.

Viant's acquisition of TVision challenges industry giants by pricing TV ads on actual viewership, moving beyond impressions to verifiable human attention.

A biotech firm is making waves with a non-viral, redosable gene delivery system showing promise for DMD and hemophilia, challenging the industry's reliance on viruses.

A new blood test could tell you if GLP-1 drugs will work for you before you start, a major leap for precision medicine in the booming obesity market.

With a star-studded new advisory board, Pilatus Biosciences accelerates its attack on cancer's metabolic defenses with its lead drug, PLT012.

Sensei Biotherapeutics begins a key trial for PIKTOR, a novel oral therapy aiming to outsmart cancer resistance in patients with advanced breast cancer.

Bridge Growth Partners launches a massive continuation fund for its real-time data platform, signaling a new gold rush for AI's foundational technology.

Minerva Neurosciences launches a pivotal Phase 3 trial for roluperidone, a potential first-in-class drug for the untreated negative symptoms of schizophrenia.

As firms struggle with AI ROI, Allego's new platform embeds practical intelligence into daily workflows, aiming to bridge the gap between hype and results.

Commvault showcases its unified, AI-enabled platform at Red Hat Summit, aiming to secure hybrid cloud workloads in a booming container market.

HealthVerity's acquisition of Symphony Health unites clinical and commercial data, promising to shatter industry silos and accelerate medical breakthroughs.

Following a key Gartner recognition, Aegis Software is integrating digital twins and AI to move factories from reactive execution to predictive intelligence.

A new survey shows millions embrace permanent freelance careers, but this freedom comes with a hidden tax on their health, family, and future stability.

New research reveals AI is not just hype for manufacturers. Early adopters see real value in months, leaving hesitant competitors far behind.

As unmanaged AI agents create a new security crisis, SlashID launches a platform to govern non-human access and rein in the risks of 'Shadow AI'.